| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |